AbbVie (ABBV) Breaking Above a Major Resistance ZoneAbbVie, Inc.BATS:ABBVisahebdadi AbbVie has decisively broken above the long-standing resistance around $245, turning a key supply zone into potential support. The strong bullish breakout suggests renewed buying momentum, although a short-term pullback to retest the breakout level remains possible before the next leg higher. Short-Term Outlook As long as price remains above $245, the bullish breakout remains valid. Targets: $260 → $270 → $280 Stop-loss: Below $242 Long-Term Outlook The long-term trend continues to favor the bulls, with the breakout confirming a continuation of the broader uptrend. If the former resistance successfully turns into support, it could become the base for another sustained rally. Targets: $280 → $300 → $320 Stop-loss: Weekly close below $235 Summary AbbVie has successfully broken above the major $245 resistance level, which is now expected to act as support. If buyers continue defending this breakout zone, the stock could extend its rally toward $270+, with the potential to reach the $300–320 area over the longer term. However, a failure to hold above $245 would weaken the breakout and increase the risk of a deeper pullback toward the $230–235 support zone.